Q3 2024 Holdings
Filed 2024-11-13 | 43 holdings | $666.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cullinan Therapeutics, Inc.(CGEM) | Common | 230031106 | $128.0M | 7,648,268 | 19.2% |
| Insmed Incorporated(INSM) | Common | 457669307 | $44.9M | 615,391 | 6.7% |
| Olema Pharmaceuticals, Inc.(OLMA) | Common | 68062P106 | $32.0M | 2,680,596 | 4.8% |
| Avidity Biosciences Inc(RNA) | Common | 05370A108 | $31.6M | 688,975 | 4.7% |
| Crinetics Pharmaceuticals Inc.(CRNX) | Common | 22663K107 | $26.9M | 525,845 | 4.0% |
| Edgewise Therapeutics Inc(EWTX) | Common | 28036F105 | $24.5M | 917,166 | 3.7% |
| Iovance Biotherapeutics Inc(IOVA) | Common | 462260100 | $22.6M | 2,406,714 | 3.4% |
| Natera Inc(NTRA) | Common | 632307104 | $22.5M | 177,099 | 3.4% |
| Rocket Pharmaceuticals, Inc.(RCKT) | Common | 77313F106 | $19.7M | 1,066,373 | 3.0% |
| Mirum Pharmaceuticals Inc(MIRM) | Common | 604749101 | $19.2M | 492,723 | 2.9% |
| Ultragenyx Pharmaceutical Inc(RARE) | Common | 90400D108 | $18.3M | 329,733 | 2.7% |
| iTeos Therapeutics, Inc.(5E7) | Common | 46565G104 | $17.8M | 1,745,943 | 2.7% |
| Moonlake Immunotherapeutics(MLTX) | Class A Ord | 61559X104 | $17.6M | 349,063 | 2.6% |
| Lantheus Holdings Inc(LNTH) | Common | 516544103 | $16.5M | 150,182 | 2.5% |
| Madrigal Pharmaceuticals Inc(MDGL) | Common | 558868105 | $15.4M | 72,395 | 2.3% |
| Disc Medicine Inc(IRON) | Common | 254604101 | $15.3M | 311,761 | 2.3% |
| Relay Therapeutics Inc.(RLAY) | Common | 75943R102 | $14.4M | 2,033,041 | 2.2% |
| Twist Bioscience Corp(TWST) | Common | 90184D100 | $13.3M | 294,930 | 2.0% |
| Revolution Medicines, Inc.(RVMD) | Common | 76155X100 | $13.2M | 291,391 | 2.0% |
| Guardant Health Inc(GH) | Common | 40131M109 | $11.5M | 499,170 | 1.7% |
| Akero Therapeutics Inc(AKRO) | Common | 00973Y108 | $11.3M | 392,544 | 1.7% |
| Kalvista Pharmaceuticals Inc(KALV) | Common | 483497103 | $10.4M | 896,915 | 1.6% |
| Compass Therapeutics, Inc.(CMPX) | Common | 20454B104 | $10.4M | 5,641,894 | 1.6% |
| Cartesian Therapeutics Inc(RNAC) | Common | 816212302 | $10.1M | 629,423 | 1.5% |
| Sutro Biopharma, Inc. | Common | 869367102 | $9.8M | 2,832,064 | 1.5% |
| Aquestive Therapeutics Inc(AQST) | Common | 03843E104 | $8.9M | 1,796,750 | 1.3% |
| Janux Therapeutics Inc(JANX) | Common | 47103J105 | $7.8M | 171,105 | 1.2% |
| Viking Therapeutics Inc(VKTX) | Common | 92686J106 | $7.7M | 120,982 | 1.1% |
| Xenon Pharmaceuticals Inc(XENE) | Common | 98420N105 | $6.5M | 165,800 | 1.0% |
| Stoke Therapeutics Inc(STOK) | Common | 86150R107 | $5.9M | 479,452 | 0.9% |
| Repare Therapeutics, Inc.(RPTX) | Common | 760273102 | $5.6M | 1,639,849 | 0.8% |
| Intellia Therapeutics, Inc.(NTLA) | Common | 45826J105 | $5.5M | 267,557 | 0.8% |
| Zentalis Pharmaceuticals, Inc.(ZNTL) | Common | 98943L107 | $5.4M | 1,465,801 | 0.8% |
| Trevi Therapeutics Inc(TRVI) | Common | 89532M101 | $5.1M | 1,538,517 | 0.8% |
| Wave Life Sciences PTE LTD(WVE) | Common | Y95308105 | $5.1M | 624,471 | 0.8% |
| Arcturus Therapeutics Holdings(ARCT) | Common | 03969T109 | $5.1M | 219,508 | 0.8% |
| Werewolf Therapeutics, Inc.(HOWL) | Common | 95075A107 | $5.1M | 2,388,011 | 0.8% |
| Adaptimmune Therapeutics plc(ADAPY) | Sponsored ADR | 00653A107 | $4.8M | 5,095,912 | 0.7% |
| ALX Oncology Holdings Inc.(ALXO) | Common | 00166B105 | $4.4M | 2,409,862 | 0.7% |
| PTC Therapeutics Inc(PTCT) | Common | 69366J200 | $3.3M | 89,715 | 0.5% |
| 89Bio Inc(ETNBGBP) | Common | 282559103 | $2.4M | 330,000 | 0.4% |
| Regenxbio Inc.(RGNX) | Common | 75901B107 | $524.5K | 50,000 | 0.1% |
| Solid Biosciences Inc(SLDB) | Common | 83422E204 | $80.3K | 11,518 | 0.0% |